
Downregulation of SOX17 promotes EndMT via TGF-β/Smad2/3 signaling in PH patients and animal models. SOX17 overexpression reverses TGF-β– and hypoxia-induced EndMT by suppressing ROCK1, reducing MYPT1 and MLC phosphorylation. Endothelial-specific SOX17 overexpression in rats mitigates vascular remodeling. These findings highlight the SOX17/TGF-β/ROCK1 pathway as a novel target for PH treatment.
Like
Save
Share